Bio-Rad pays US$55 million to settle FCPA charges

Life science research company Bio-Rad Laboratories has agreed to pay US$55 million to settle FCPA charges brought by the US Department of Justice (DoJ) and the US Securities and Exchange Commission (SEC), the authorities announced in separate statements on Monday.

Unlock unlimited access to all Global Investigations Review content